Brilliant Blue G

CHEMBL4173394 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
854.0 g/mol
LogP
Phase
4

A blue dye used in ophthalmic surgery to stain the internal limiting membrane of the retina, aiding surgeons in precisely identifying and removing it during vitreoretinal procedures. It improves visualization during delicate eye surgery, reducing the risk of accidental damage to the macula. It is used as a surgical aid rather than a therapeutic agent.

分子量

854.0000 g/mol

TPSA

159.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOc1ccc(Nc2ccc(/C(=C3/C=C/C(=[N+](/CC)Cc4cccc(S(=O)(=O)[O-])c4)C=C3C)c3ccc(N(CC)Cc4cccc(S(=O)(=O)[O-])c4)cc3C)cc2)cc1.[Na+]

InChI

InChI=1S/C47H49N3O7S2.Na/c1-6-49(31-35-11-9-13-43(29-35)58(51,52)53)40-21-25-45(33(4)27-40)47(37-15-17-38(18-16-37)48-39-19-23-42(24-20-39)57-8-3)46-26-22-41(28-34(46)5)50(7-2)32-36-12-10-14-44(30-36)59(54,55)56;/h9-30H,6-8,31-32H2,1-5H3,(H2,51,52,53,54,55,56);/q;+1/p-1

Molecular Formula

C47H48N3NaO7S2

HBD / HBA

1 / 9

回転可能結合数

13

重原子数

60

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A blue dye used in ophthalmic surgery to stain the internal limiting membrane of the retina, aiding surgeons in precisely identifying and removing it during vitreoretinal procedures. It improves visualization during delicate eye surgery, reducing the risk of accidental damage to the macula. It is used as a surgical aid rather than a therapeutic agent.

Yes, Brilliant Blue G is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4173394. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 61363. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.